For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Nafarelin acetate - Transgender Health - Children & Young People
PAD Profile : Nafarelin acetate - Transgender Health - Children & Young People
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
Other Indications
Additional Documents
Committee Recommendations
With the publication of the final Cass Report and new NHSE commissioning policies, the APC has agreed an AMBER status for puberty supressing hormones in children and young people under the following circumstances:
i. ONLY for current NHS and private patients at least until next reviewed by the service lead clinician. Always ensure that appropriate shared care protocols are in place before continuing prescribing. Private patients should be advised of the new NHS policy and recommendation made to return to the private provider for consideration of stopping.
ii. DO NOT initiate in any new patients